SENTA Partners is proud to announce its inclusion on the 2025 Inc. 5000 list, ranking at No. 2679. This prestigious list recognizes the fastest-growing private companies in America and is a hallmark of entrepreneurial success. This is the third year in a row that SENTA has been recognized by Inc. Magazine. SENTA Partners is backed by Shore Capital Partners, and is committed to partnering with leading physicians to build a premier network of ENT and Allergy services in the U.S.
The Inc. 5000 list represents a unique look at the most successful companies within the American economy’s most dynamic segment—its independent businesses. SENTA’s inclusion reflects its rapid growth, commitment to clinical excellence, and dedication to delivering high-quality, patient-centered care.
“We are honored to be recognized by Inc. 5000 for a third year in a row,” said Adam Low, CEO of SENTA Partners. “With a focus on providing the highest-quality care and patient experiences, this achievement is a testament to the hard work of our physicians, providers, and team members who are passionate about improving lives through exceptional ENT and allergy care. With out the hard work and dedication from all levels of the organization, from the clinics to the support center, this level of organic growth would not have been possible.”
This year’s Inc. 5000 honorees have demonstrated exceptional growth while navigating economic uncertainty, inflationary pressure, and a fluctuating labor market.
Since being founded in 2019, SENTA has completed 15 health care partnerships and now boasts 1,100 employees, including 200 providers across seven states in the Southern region. SENTA’s growth strategy is rooted in empowering physicians, investing in innovation, and maintaining a strong culture of collaboration. By combining clinical autonomy with operational support, SENTA enables its partner practices to thrive in today’s evolving healthcare landscape.
ABOUT INC. AND THE INC. 5000 METHODOLOGY
Inc. is the leading media brand and playbook for the entrepreneurs and business leaders shaping our future. Through its journalism, Inc. aims to inform, educate, and elevate the profile of its community: the risk-takers, the innovators, and the ultra-driven go-getters who are creating the future of business. Inc. is published by Mansueto Ventures LLC, along with fellow leading business publication Fast Company. Companies on the 2025 Inc. 5000 are ranked according to percentage revenue growth from 2021 to 2024. To qualify, companies must have been founded and generating revenue by March 31, 2021. They must be U.S.-based, privately held, for-profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2024. (Since then, some on the list may have gone public or been acquired.) The minimum revenue required for 2021 is $100,000; the minimum for 2024 is $2 million. As always, Inc. reserves the right to decline applicants for subjective reasons. For more information, visit www.inc.com.
ABOUT SENTA PARTNERS
Southern Ear, Nose, Throat and Allergy Physicians (SENTA) is a leading community of the finest ENT and Allergy/Immunology specialists in the Southern region. SENTA provides the highest quality allergy, asthma, immunology, and otolaryngology care leading to better patient outcomes. Founded in 2019 with an investment from Shore Capital Partners, SENTA provides strategic, operational, and administrative support to our ENT and Allergy partner practices, empowering physicians to focus on their patients. SENTA is a three-time honoree on the INC. 5000 list of fastest-growing private companies in America (2023, 2024, 2025). For additional information on SENTA, please visit www.sentapartners.com.
ABOUT SHORE CAPITAL PARTNERS
Shore Capital, a Chicago based private equity firm with offices in Nashville, is an investor in microcap companies in the Healthcare, Food and Beverage, Business Services, Industrial, and Real Estate industries. Shore’s strategy is to support management partners to grow faster with less risk, through access to capital, world class board and operational resources, and unmatched networking, development, and shared learnings across the portfolio. From 2020-2023 Shore received recognition from Inc Magazine as a 4x Top Founder Friendly Investor and by Pitchbook research for being the global leader in Private Equity total deal volume. Shore targets investments in proven, successful private companies with superior management teams, stable cash flow, and significant potential to grow through industry consolidation and organic growth to generate value for shareholders. Shore has over $7 billion of assets under management and in additional investment platforms to which it provides business and operational consulting services. For more information, including with respect to these awards and investment platforms, please visit: www.shorecp.com.